自我认同黑人浆细胞疾病患者适应性免疫增强与炎症反应降低
该研究通过质谱流式与单细胞RNA测序分析128份骨髓穿刺样本,发现浆细胞疾病进展伴随免疫细胞组成显著变化。自我认同黑人患者在初诊和治疗后多发性骨髓瘤中终末分化T细胞比例更高、单核细胞更低,且差异基因富集于E2F靶点和G2-M检查点,而炎症相关通路下调,并在286例MM独立数据集中验证。
要点
- 浆细胞疾病进展伴随幼稚向效应T细胞转变及B细胞、MAIT、pDCs下降。
- 自我认同黑人MM患者终末分化T细胞比例更高、单核细胞更低。
- 自我认同种族与非洲遗传相似性显著关联MM免疫微环境重塑。
核心结论
- 自我认同种族和非洲遗传相似性与多发性骨髓瘤免疫肿瘤微环境重塑显著相关,可能影响疾病生物学和治疗反应。
研究设计与样本
- 研究对128份骨髓穿刺样本进行质谱流式和单细胞RNA测序分析。
- 在286例多发性骨髓瘤患者的MMRF免疫图谱独立数据集中进行验证。
主要发现
- 疾病进展伴随幼稚向效应T细胞转变,B细胞、MAIT和pDCs下降,单核细胞增加。
- 初诊和治疗后MM中,自我认同黑人患者终末分化T细胞相对比例更高、单核细胞更低。
- 自我认同黑人个体中过表达基因富集于E2F靶点和G2-M检查点,下调基因富集于TNF-α/NF-kB、干扰素和炎症反应通路。
临床怎么用
- 解读MM免疫微环境时需考虑患者自我认同种族和遗传 ancestry 的影响。
- 这些免疫差异可能为疾病生物学和治疗反应提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The immune tumor microenvironment (iTME) plays a crucial role in disease biology of plasma cell (PC) dyscrasias, but remains poorly characterized in self-identified Black individuals, a population at increased risk. Mass cytometry and scRNA-seq of 128 bone marrow aspirates revealed significant changes in immune cell composition across the disease spectrum, including shifts from naïve to effector T cells with declines in B cells, MAIT, pDCs, and increases in monocytes with disease progression. Self-identified Black patients had higher relative proportions of terminally differentiated T cells and lower monocytes in newly diagnosed and treated multiple myeloma (MM). ScRNA-seq revealed genes overexpressed in self-identified Black individuals were enriched for E2F targets and G2-M checkpoints, while reduced genes were enriched for TNF-α/NF-kB, interferon and inflammatory responses pathways. These findings were supported by genetic ancestry and validated in an independent dataset of 286 patients with MM from the MMRF Immune Atlas. Self-identified race and African genetic similarity are significantly associated with remodeling the MM iTME, with potential implications for disease biology and treatment response.
引用
- Tang H, Pilcher WC, Yan H, et al. Enriched Adaptive Immunity and Reduced Inflammatory Response in Plasma Cell Disorders of Self-Identified Black Patients. Blood. 2026. PMID: 42832394. doi:10.1182/blood.2026033998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。